Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patients

Lancet. 1994 Nov 5;344(8932):1305-6. doi: 10.1016/s0140-6736(94)90797-8.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • Drug Combinations
  • Drug Costs
  • Erythropoietin / economics
  • Erythropoietin / therapeutic use*
  • Ferric Compounds / economics
  • Ferric Compounds / therapeutic use*
  • Humans
  • Infusions, Intravenous
  • Kidney Failure, Chronic / complications*
  • Renal Replacement Therapy*
  • Solutions
  • Sucrose / economics
  • Sucrose / therapeutic use*

Substances

  • Drug Combinations
  • Ferric Compounds
  • Solutions
  • Erythropoietin
  • ferric hydroxide
  • Sucrose